Eric M. Morrow received his PhD in genetics and neurodevelopment at Harvard University. He received his MD degree from the Health Science Training (HST) Program at Massachusetts Institute of Technology and Harvard Medical School. He conducted further clinical and scientific training in neurology and psychiatry at Harvard Medical School. Dr. Morrow's research focuses on normal molecular mechanisms of brain development, and genetic perturbations that underlie disorders of human cognitive development, including autism and intellectual disability.
The laboratory investigates mechanisms in neuronal organelles, such as endosomes, lysosomes and mitochondria, including also neurometabolism. Dr. Morrow and his colleagues have focused on novel human neurogenetic syndromes. Increasingly study of these syndromes, such as Christianson Syndrome and GPT2 Deficiency, have led his laboratory to investigate mechanisms in selective neuronal vulnerability and neurodegeneration. The laboratory is also working on molecular therapies for these neurogenetic disorders. His research has been funded by NIMH, NINDS and NIA.
| Kavanaugh BC, Elacio J, Best CR, St Pierre DG, Pescosolido MF, Ouyang Q, Biedermann J, Bradley RS, Liu JS, Jones RN, Morrow EM. "Christianson syndrome across the lifespan: genetic mutations and longitudinal study in children, adolescents, and adults." Journal of Medical Genetics, 2024. |
| Morrow, Eric M. "Early Human Postnatal Brain Development Through the Lens of Rare Genetic Disorders." Biological Psychiatry, vol. 90, no. 5, 2021, pp. 281-282. |
| Lizarraga SB, Ma L, Maguire AM, van Dyck LI, Wu Q, Ouyang Q, Kavanaugh BC, Nagda D, Livi LL, Pescosolido MF, Schmidt M, Alabi S, Cowen MH, Brito-Vargas P, Hoffman-Kim D, Gamsiz Uzun ED, Schlessinger A, Jones RN, Morrow EM. "Human neurons from Christianson syndrome iPSCs reveal mutation-specific responses to rescue strategies." Science Translational Medicine, vol. 13, no. 580, 2021. |
| McCormick, Carolyn E. B., Kavanaugh, Brian C., Sipsock, Danielle, Righi, Giulia, Oberman, Lindsay M., Moreno De Luca, Daniel, Gamsiz Uzun, Ece D., Best, Carrie R., Jerskey, Beth A., Quinn, Joanne G., Jewel, Susan B., Wu, Pei‐Chi, McLean, Rebecca L., Levine, Todd P., Tokadjian, Hasmik, Perkins, Kayla A., Clarke, Elaine B., Dunn, Brittany, Gerber, Alan H., Tenenbaum, Elena J., Anders, Thomas F., Sheinkopf, Stephen J., Morrow, Eric M., None, None. "Autism Heterogeneity in a Densely Sampled U.S. Population: Results From the First 1,000 Participants in the RI-CART Study." Autism Research, vol. 13, no. 3, 2020, pp. 474-488. |
| Moreno-De-Luca, Daniel, Kavanaugh, Brian C., Best, Carrie R., Sheinkopf, Stephen J., Phornphutkul, Chanika, Morrow, Eric M. "Clinical Genetic Testing in Autism Spectrum Disorder in a Large Community-Based Population Sample." JAMA Psychiatry, 2020. |
| Warren EB, Morrow EM. "Mitochondrial Function in 22q11 Deletion Syndrome." Neuron, vol. 102, no. 6, 2019, pp. 1089-1091. |
| van Dyck LI, Morrow EM. "Genetic control of postnatal human brain growth." Current opinion in neurology, vol. 30, no. 1, 2017, pp. 114-124. |
| Ma L, Ouyang Q, Werthmann GC, Thompson HM, Morrow EM. "Live-cell Microscopy and Fluorescence-based Measurement of Luminal pH in Intracellular Organelles." Frontiers in Cell and Developmental Biology, vol. 5, 2017, pp. 71. |
| Ouyang, Qing, Nakayama, Tojo, Baytas, Ozan, Davidson, Shawn M., Yang, Chendong, Schmidt, Michael, Lizarraga, Sofia B., Mishra, Sasmita, EI-Quessny, Malak, Niaz, Saima, Gul Butt, Mirrat, Imran Murtaza, Syed, Javed, Afzal, Chaudhry, Haroon Rashid, Vaughan, Dylan J., Hill, R. Sean, Partlow, Jennifer N., Yoo, Seung-Yun, Lam, Anh-Thu N., Nasir, Ramzi, Al-Saffar, Muna, Barkovich, A. James, Schwede, Matthew, Nagpal, Shailender, Rajab, Anna, DeBerardinis, Ralph J., Housman, David E., Mochida, Ganeshwaran H., Morrow, Eric M. "Mutations in mitochondrial enzyme GPT2 cause metabolic dysfunction and neurological disease with developmental and progressive features." Proceedings of the National Academy of Sciences, vol. 113, no. 38, 2016, pp. E5598-E5607. |
| Young-Pearse TL, Morrow EM. "Modeling developmental neuropsychiatric disorders with iPSC technology: challenges and opportunities." Current opinion in neurobiology, vol. 36, 2015, pp. 66-73. |
| Howe YJ, Yatchmink Y, Viscidi EW, Morrow EM. "Ascertainment and gender in autism spectrum disorders." Struggle and Success: Contract Negotiations and Renegotiations for Women Child and Adolescent Psychiatrist Through The Lens of Intersectionality and Structural Bias, vol. 53, no. 6, 2014, pp. 698-700. |
| Pescosolido, Matthew F, Schwede, Matthew, Johnson Harrison, Ashley, Schmidt, Michael, Gamsiz, Ece D, Chen, Wendy S, Donahue, John P, Shur, Natasha, Jerskey, Beth A, Phornphutkul, Chanika, Morrow, Eric M. "Expansion of the clinical phenotype associated with mutations in activity-dependent neuroprotective protein." Journal of Medical Genetics, vol. 51, no. 9, 2014, pp. 587-9. |
| Pescosolido, Matthew F., Stein, David M., Schmidt, Michael, El Achkar, Christelle Moufawad, Sabbagh, Mark, Rogg, Jeffrey M., Tantravahi, Umadevi, McLean, Rebecca L., Liu, Judy S., Poduri, Annapurna, Morrow, Eric M. "Genetic and phenotypic diversity of NHE 6 mutations in Christianson syndrome." Annals of neurology, vol. 76, no. 4, 2014, pp. 581-593. |
| Stein DM, Gerber A, Morrow EM. "Inaugural Christianson Syndrome Association conference: families meeting for the first time." Journal of Neurodevelopmental Disorders, vol. 6, no. 1, 2014, pp. 13. |
| Ouyang Q, Lizarraga SB, Schmidt M, Yang U, Gong J, Ellisor D, Kauer JA, Morrow EM. "Christianson syndrome protein NHE6 modulates TrkB endosomal signaling required for neuronal circuit development." Neuron, vol. 80, no. 1, 2013, pp. 97-112. |
| Viscidi EW, Triche EW, Pescosolido MF, McLean RL, Joseph RM, Spence SJ, Morrow EM. "Clinical characteristics of children with autism spectrum disorder and co-occurring epilepsy." PLoS ONE, vol. 8, no. 7, 2013, pp. e67797. |
| Pescosolido MF, Gamsiz ED, Nagpal S, Morrow EM. "Distribution of Disease-Associated Copy Number Variants Across Distinct Disorders of Cognitive Development." Journal of the American Academy of Child & Adolescent Psychiatry, vol. 52, no. 4, 2013, pp. 414-430.e14. |
| Gamsiz ED, Viscidi EW, Frederick AM, Nagpal S, Sanders SJ, Murtha MT, Schmidt M, Simons Simplex Collection Genetics Consortium, Triche EW, Geschwind DH, State MW, Istrail S, Cook EH Jr, Devlin B, Morrow EM. "Intellectual disability is associated with increased runs of homozygosity in simplex autism." The American Journal of Human Genetics, vol. 93, no. 1, 2013, pp. 103-9. |
| Abrahams BS, Arking DE, Campbell DB, Mefford HC, Morrow EM, Weiss LA, Menashe I, Wadkins T, Banerjee-Basu S, Packer A. "SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs)." Molecular autism, vol. 4, no. 1, 2013, pp. 36. |
| Morrow, Eric M. "Genomic Copy Number Variation in Disorders of Cognitive Development." Struggle and Success: Contract Negotiations and Renegotiations for Women Child and Adolescent Psychiatrist Through The Lens of Intersectionality and Structural Bias, vol. 49, no. 11, 2010, pp. 1091-1104. |
| Walsh CA, Morrow EM, Rubenstein JL. "Autism and brain development." Cell, vol. 135, no. 3, 2008, pp. 396-400. |
Neurodevelopmental disorders such as autism and intellectual disability are common and cause profound morbidity in populations worldwide. The associated costs to society are high and that to families are immeasurable. Intellectual disability (ID), the most common developmental disability, occurs in 2% of people and is a major cause of lifelong disability across the world.
The Morrow lab investigates the genetic and molecular mechanisms underlying disorders of cognitive development. The long-term aim of this research is to establish a basic foundation for improved genetic diagnoses and innovative treatment interventions designed to enhance cognitive and functional gains for patients. Because these disorders are highly genetic and in order to identify core molecular mechanisms, the study of novel human neurogenetic syndromes has been a principal focus. In complement to this, molecular neuroscicence studies of identified pathways are underway.
Research in the Morrow lab bridges campus and medical school efforts at Brown. The Morrow lab is located at the Laboratories for Molecular Medicine at 70 Ship Street. The Lab partners with the Developmental Disorders Genetics Research Program (DDGRP) in the Department of Psychiatry and Human Behavior.
| Year | Degree | Institution |
|---|---|---|
| 2007 | MSc | Harvard University |
| 2001 | MD | Harvard University |
| 1998 | PhD | Harvard University |
| 1992 | ScB | Massachusetts Institute of Technology |
Dr. Morrow's teaching and mentorship bridges from the classroom to the clinic. He enjoys taking an active role in, and is dedicated to, mentoring students and junior faculty. He has formally mentored numerous undergraduate students, graduate students, medical students, post-doctoral research assistants, and junior faculty. These mentoring activities range from supervision of short-term independent research projects or research rotations to serving as a graduate program thesis advisor to sponsoring clinical and basic post-doctoral research. Dr. Morrow received the 2011-2012 Psychiatry Research Mentor Award from the Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University.
| BIOL 1545 - Human Genetics and Genomics |
| BIOL 2340 - Neurogenetics and Disease |
| BIOL 2545 - Human Genetics and Genomics |
